Home › Idiopathic Thrombocytopenic Purpura › Ohio
Idiopathic Thrombocytopenic Purpura clinical trials in Ohio
3 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Ohio.
Cities in Ohio
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- University Hospitals Cleveland Medical Center, Cleveland
- Ohio State University Hospital East, Columbus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 1, 2026 · NCT06544499From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.